CASC2 and neoplasm: Miao et al. (2019) reported that the downregulation of the long noncoding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2, enhanced tumor development, increased miR-18a-5p levels, and reduced the expression of RBBP8 in nasopharyngeal carcinoma (NPC).